Acquired by Viatris in Jan 2023
OYST - Oyster Point Pharma, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Princeton,
United States
Type: Equity
OYST price evolution
OYST
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $68.8 | $104.94 | $143.43 | $193.43 |
| Short term investments | ||||
| Net receivables | $13.18 | $10.92 | $5.74 | $6.66 |
| Inventory | $6.96 | $6.64 | $4.09 | $6.09 |
| Total current assets | $97.71 | $132.72 | $167.35 | $215.25 |
| Long term investments | $0.89 | $0.89 | $0.89 | $0.89 |
| Property, plant & equipment | $4.92 | $5.2 | $5.26 | $5.4 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $11.49 | $11.22 | $9.37 | $7.37 |
| Total investments | $0.89 | $0.89 | $0.89 | $0.89 |
| Total assets | $109.2 | $143.94 | $176.72 | $222.62 |
| Current liabilities | ||||
| Accounts payable | $4.14 | $4.72 | $2.6 | $6.5 |
| Deferred revenue | ||||
| Short long term debt | $0.69 | $0.72 | $0.71 | $0.8 |
| Total current liabilities | $29.2 | $31.13 | $23.03 | $28.8 |
| Long term debt | $94.03 | $93.42 | $92.64 | $91.93 |
| Total noncurrent liabilities | $102.21 | $102.03 | $97.7 | $94.28 |
| Total debt | $94.72 | $94.14 | $93.36 | $92.73 |
| Total liabilities | $131.4 | $133.16 | $120.73 | $123.08 |
| Shareholders' equity | ||||
| Retained earnings | -$389.99 | -$353.24 | -$303.3 | -$255.41 |
| Other shareholder equity | ||||
| Total shareholder equity | -$22.2 | $10.78 | $55.99 | $99.54 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $193.43 | $192.65 | $139.2 | $5.23 |
| Short term investments | ||||
| Net receivables | $6.66 | |||
| Inventory | $6.09 | |||
| Total current assets | $215.25 | $196.37 | $142.18 | $5.62 |
| Long term investments | $0.89 | |||
| Property, plant & equipment | $5.4 | $1.48 | $0.98 | $0.07 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $7.37 | $1.54 | $1.03 | $0.09 |
| Total investments | $0.89 | |||
| Total assets | $222.62 | $197.91 | $143.21 | $5.7 |
| Current liabilities | ||||
| Accounts payable | $6.5 | $2.28 | $0.5 | $0.46 |
| Deferred revenue | ||||
| Short long term debt | $0.8 | $0.42 | $0.3 | $0.06 |
| Total current liabilities | $28.8 | $10.98 | $5.4 | $0.94 |
| Long term debt | $91.93 | $0.27 | $0.51 | $0.01 |
| Total noncurrent liabilities | $94.28 | $0.27 | $0.51 | $0.01 |
| Total debt | $92.73 | $0.69 | $0.81 | $0.06 |
| Total liabilities | $123.08 | $11.25 | $5.91 | $0.95 |
| Shareholders' equity | ||||
| Retained earnings | -$255.41 | -$154.75 | -$84.23 | -$38.52 |
| Other shareholder equity | ||||
| Total shareholder equity | $99.54 | $186.66 | $137.3 | -$38.24 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5.59 | $4.69 | $2.7 | $6.6 |
| Cost of revenue | $1.35 | $1.31 | $0.34 | $1.52 |
| Gross Profit | $4.24 | $3.38 | $2.37 | $5.07 |
| Operating activities | ||||
| Research & development | $3.91 | $4.66 | $4.68 | $5.46 |
| Selling, general & administrative | $34.24 | $42.11 | $39.9 | $38.55 |
| Total operating expenses | $38.16 | $46.77 | $44.58 | $44.01 |
| Operating income | -$33.91 | -$43.39 | -$42.21 | -$38.94 |
| Income from continuing operations | ||||
| EBIT | -$33.25 | -$46.79 | -$44.83 | -$39.45 |
| Income tax expense | ||||
| Interest expense | $3.5 | $3.16 | $3.07 | $2.61 |
| Net income | ||||
| Net income | -$36.75 | -$49.94 | -$47.89 | -$42.06 |
| Income (for common shares) | -$36.75 | -$49.94 | -$47.89 | -$42.06 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $24.54 | |||
| Cost of revenue | $1.52 | |||
| Gross Profit | $23.01 | |||
| Operating activities | ||||
| Research & development | $24.23 | $39.81 | $33.63 | $13.76 |
| Selling, general & administrative | $95.44 | $31.18 | $13.67 | $2.98 |
| Total operating expenses | $119.67 | $70.99 | $47.3 | $16.74 |
| Operating income | -$96.66 | -$70.99 | -$47.3 | -$16.74 |
| Income from continuing operations | ||||
| EBIT | -$96.92 | -$70.52 | -$45.71 | -$16.5 |
| Income tax expense | ||||
| Interest expense | $3.73 | |||
| Net income | ||||
| Net income | -$100.66 | -$70.52 | -$45.71 | -$16.5 |
| Income (for common shares) | -$100.66 | -$70.52 | -$45.71 | -$16.5 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$36.75 | -$49.94 | -$47.89 | -$42.06 |
| Operating activities | ||||
| Depreciation | $0.28 | $0.36 | $0.33 | $0.22 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.77 | $4.18 | $4.36 | $3.1 |
| Total cash flows from operations | -$35.97 | -$38.83 | -$49.7 | -$41.48 |
| Investing activities | ||||
| Capital expenditures | -$0.12 | -$0.09 | -$0.23 | |
| Investments | ||||
| Total cash flows from investing | -$0.12 | -$0.09 | -$0.23 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0 | $0.54 | $0.08 | $0.98 |
| Net borrowings | -$0.17 | -$0.08 | -$0.21 | $49.93 |
| Total cash flows from financing | -$0.17 | $0.46 | -$0.22 | $50.92 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$36.14 | -$38.49 | -$50.01 | $9.21 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | -$100.66 | -$70.52 | -$45.71 | -$16.5 |
| Operating activities | ||||
| Depreciation | $0.68 | $0.46 | $0.02 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $11.95 | $6.97 | $3.27 | $0.15 |
| Total cash flows from operations | -$89.37 | -$58.4 | -$40.81 | -$17.08 |
| Investing activities | ||||
| Capital expenditures | -$1.49 | -$0.7 | -$0.2 | |
| Investments | ||||
| Total cash flows from investing | -$1.49 | -$0.7 | -$0.2 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.59 | $112.91 | $82.13 | |
| Net borrowings | $90.08 | |||
| Total cash flows from financing | $91.64 | $112.55 | $174.99 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.79 | $53.45 | $133.97 | -$17.08 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 26.83M |
| Revenue | $19.58M |
|---|---|
| EBITDA | -$163.13M |
| EBIT | -$164.32M |
| Net Income | -$176.65M |
| Revenue Q/Q | -68.84% |
| Revenue Y/Y | 9.15% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | -0.83 |
| Cash/Share | 2.56 |
| EPS | -$6.58 |
|---|---|
| ROA | -108.29% |
| ROE | -490.33% |
| Debt/Equity | 1.24 |
|---|---|
| Net debt/EBITDA | -0.38 |
| Current ratio | 3.35 |
| Quick ratio | 3.11 |